DASATINIB

DASATINIB was reported 9292 times

DASATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHILADELPHIA CHROMOSOME POSITIVE 250 0.3420
1 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 27 0.2812
2 BLAST CELL PROLIFERATION 14 0.2456
3 CHYLOTHORAX 173 0.2399
4 CYTOGENETIC ANALYSIS ABNORMAL 216 0.2061
5 PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA 30 0.1840
6 CHRONIC MYELOID LEUKAEMIA RECURRENT 95 0.1737
7 BLAST CELL CRISIS 46 0.1386
8 PRIMARY EFFUSION LYMPHOMA 11 0.1279
9 LARGE GRANULAR LYMPHOCYTOSIS 41 0.1220
10 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 148 0.1199
11 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 53 0.1188
12 CLONAL EVOLUTION 11 0.1058
13 POLYMERASE CHAIN REACTION POSITIVE 33 0.0946
14 CENTRAL NERVOUS SYSTEM NEOPLASM 15 0.0932
15 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 229 0.0887
16 GENE MUTATION IDENTIFICATION TEST POSITIVE 37 0.0879
17 LYMPHOID TISSUE HYPERPLASIA 31 0.0876
18 EXPOSURE VIA BODY FLUID 64 0.0814
19 ASPIRATION PLEURAL CAVITY 60 0.0780
20 CENTRAL NERVOUS SYSTEM LEUKAEMIA 28 0.0712
21 EMERGENCY CARE EXAMINATION 48 0.0708
22 CHRONIC MYELOID LEUKAEMIA 305 0.0660
23 DRUG RESISTANCE MUTATION 11 0.0618
24 LEUKAEMIA RECURRENT 96 0.0567
25 GRAFT VERSUS HOST DISEASE IN EYE 13 0.0563
26 CHROMOSOME ANALYSIS ABNORMAL 14 0.0551
27 ENTEROCOLITIS HAEMORRHAGIC 81 0.0547
28 PLEURAL EFFUSION 3282 0.0539
29 MINIMAL RESIDUAL DISEASE 26 0.0538
30 PERIPHERAL ARTERY STENOSIS 22 0.0459
31 SUBDURAL HYGROMA 12 0.0395
32 GENE MUTATION 78 0.0394
33 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 10 0.0392
34 BONE MARROW TRANSPLANT 69 0.0364
35 MYELOID LEUKAEMIA 17 0.0339
36 ACUTE LYMPHOCYTIC LEUKAEMIA 93 0.0328
37 CYTOMEGALOVIRUS COLITIS 73 0.0317
38 B-CELL TYPE ACUTE LEUKAEMIA 23 0.0313
39 ACQUIRED GENE MUTATION 38 0.0290
40 REMISSION NOT ACHIEVED 17 0.0273
41 LYMPHOCYTIC LEUKAEMIA 11 0.0270
42 PRESCRIBED UNDERDOSE 506 0.0253
43 HYPHAEMA 13 0.0249
44 DRUG RESISTANCE 612 0.0238
45 ENTEROCOCCAL BACTERAEMIA 25 0.0236
46 CYTOMEGALOVIRUS ENTEROCOLITIS 18 0.0234
47 BONE MARROW DISORDER 70 0.0231
48 PULMONARY OEDEMA 1017 0.0227
49 GASTRIC ANTRAL VASCULAR ECTASIA 12 0.0227
50 PERICARDIAL EFFUSION 510 0.0220
51 HYDROTHORAX 18 0.0217
52 BLAST CELLS PRESENT 10 0.0208
53 INTERMITTENT CLAUDICATION 31 0.0195
54 MYOPATHY TOXIC 12 0.0194
55 CYTOGENETIC ABNORMALITY 21 0.0186
56 GRAFT VERSUS HOST DISEASE IN LIVER 13 0.0182
57 BLAST CELL COUNT INCREASED 19 0.0181
58 DRUG CLEARANCE DECREASED 23 0.0176
59 STREPTOCOCCAL BACTERAEMIA 19 0.0175
60 STEM CELL TRANSPLANT 43 0.0172
61 HYPERPLASIA 15 0.0167
62 HEPATOTOXICITY 368 0.0165
63 BONE MARROW OEDEMA 17 0.0164
64 MARROW HYPERPLASIA 11 0.0161
65 EFFUSION 22 0.0161
66 ADVERSE EVENT 1478 0.0160
67 FUSARIUM INFECTION 11 0.0157
68 PULMONARY HYPERTENSION 325 0.0156
69 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 22 0.0156
70 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 14 0.0151
71 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 32 0.0150
72 CYTOPENIA 177 0.0144
73 MYOPERICARDITIS 11 0.0141
74 ENTEROCOLITIS INFECTIOUS 13 0.0141
75 GRAFT VERSUS HOST DISEASE IN SKIN 31 0.0141
76 SCROTAL SWELLING 13 0.0139
77 HAEMATOTOXICITY 130 0.0137
78 PLEURISY 80 0.0135
79 BASOPHIL COUNT INCREASED 10 0.0132
80 PULMONARY ARTERIAL HYPERTENSION 190 0.0131
81 FLUID RETENTION 663 0.0130
82 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 53 0.0130
83 CEREBRAL TOXOPLASMOSIS 12 0.0128
84 RIGHT VENTRICULAR DYSFUNCTION 14 0.0127
85 GASTROINTESTINAL TOXICITY 61 0.0127
86 DEMYELINATING POLYNEUROPATHY 13 0.0126
87 NEUTROPENIC INFECTION 12 0.0125
88 LEUKAEMIA 118 0.0125
89 PLATELET TRANSFUSION 16 0.0124
90 LOSS OF THERAPEUTIC RESPONSE 39 0.0122
91 PERIORBITAL OEDEMA 62 0.0119
92 STRONGYLOIDIASIS 19 0.0118
93 LYMPHOCYTOSIS 25 0.0116
94 HAEMOTHORAX 33 0.0114
95 GRAFT VERSUS HOST DISEASE 78 0.0108
96 SYSTEMIC CANDIDA 27 0.0107
97 LIPASE INCREASED 78 0.0102
98 ACUTE GRAFT VERSUS HOST DISEASE 46 0.0100
99 MALLORY-WEISS SYNDROME 12 0.0094
100 PACKED RED BLOOD CELL TRANSFUSION 12 0.0091
101 NEPHROTIC SYNDROME 62 0.0090
102 PNEUMONIA KLEBSIELLA 16 0.0087
103 PERIPHERAL ARTERY OCCLUSION 12 0.0085
104 FULL BLOOD COUNT INCREASED 10 0.0084
105 AMYLASE INCREASED 31 0.0084
106 MALIGNANT NEOPLASM PROGRESSION 860 0.0084
107 DRUG INTOLERANCE 807 0.0083
108 SKIN TOXICITY 47 0.0083
109 MALIGNANT PLEURAL EFFUSION 14 0.0083
110 CAPILLARY LEAK SYNDROME 17 0.0082
111 EJECTION FRACTION ABNORMAL 10 0.0082
112 SPLENOMEGALY 95 0.0081
113 MULTIPLE-DRUG RESISTANCE 25 0.0081
114 NEOPLASM RECURRENCE 27 0.0080
115 HOSPITALISATION 1223 0.0080
116 INFECTIOUS PLEURAL EFFUSION 12 0.0079
117 FULL BLOOD COUNT DECREASED 158 0.0078
118 GROWTH RETARDATION 23 0.0078
119 CEREBELLAR SYNDROME 17 0.0078
120 CHRONIC GRAFT VERSUS HOST DISEASE 28 0.0077
121 CYTOMEGALOVIRUS INFECTION REACTIVATION 34 0.0077
122 GENERALISED OEDEMA 95 0.0077
123 PNEUMONIA FUNGAL 30 0.0076
124 WHITE BLOOD CELL DISORDER 20 0.0075
125 BONE PAIN 414 0.0071
126 PULMONARY TOXICITY 49 0.0069
127 PANCREATIC ENZYMES INCREASED 10 0.0068
128 THERAPY CHANGE 67 0.0068
129 TRANSPLANT 16 0.0067
130 CYTOMEGALOVIRUS TEST POSITIVE 12 0.0067
131 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
132 LARGE INTESTINAL ULCER 18 0.0066
133 PANCYTOPENIA 368 0.0066
134 BONE MARROW FAILURE 132 0.0065
135 BLOOD DISORDER 52 0.0065
136 NORMAL NEWBORN 35 0.0064
137 PERIPHERAL VASCULAR DISORDER 33 0.0064
138 PLATELET DISORDER 16 0.0063
139 CARDIAC TAMPONADE 30 0.0063
140 TRANSFUSION 66 0.0063
141 NEUTROPENIC COLITIS 13 0.0063
142 HEPATOSPLENOMEGALY 16 0.0062
143 SKIN HYPOPIGMENTATION 11 0.0062
144 ENTEROCOCCAL INFECTION 30 0.0062
145 DRUG TOLERANCE DECREASED 17 0.0060
146 EMPYEMA 12 0.0060
147 LEUKOCYTOSIS 108 0.0060
148 MUCOSAL INFLAMMATION 156 0.0060
149 NIPPLE PAIN 12 0.0059
150 SECOND PRIMARY MALIGNANCY 49 0.0059
151 THROMBOCYTOPENIA 658 0.0059
152 OEDEMA 310 0.0057
153 CYSTITIS HAEMORRHAGIC 23 0.0057
154 WHITE BLOOD CELL COUNT ABNORMAL 36 0.0056
155 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 13 0.0056
156 WHITE BLOOD CELL COUNT INCREASED 214 0.0056
157 FEBRILE NEUTROPENIA 369 0.0056
158 LUNG INFILTRATION 49 0.0055
159 LEFT VENTRICULAR FAILURE 19 0.0055
160 THROMBOCYTOSIS 20 0.0055
161 LOBAR PNEUMONIA 10 0.0054
162 PLATELET COUNT DECREASED 574 0.0054
163 SUBDURAL HAEMATOMA 77 0.0054
164 HYPERURICAEMIA 22 0.0053
165 TUMOUR LYSIS SYNDROME 47 0.0053
166 EXERCISE TOLERANCE DECREASED 30 0.0052
167 ENTEROCOLITIS 30 0.0052
168 RECURRENT CANCER 21 0.0051
169 PERIPHERAL ISCHAEMIA 21 0.0051
170 SUBDURAL HAEMORRHAGE 14 0.0051
171 LACTOSE INTOLERANCE 13 0.0051
172 THERAPEUTIC RESPONSE DELAYED 14 0.0050
173 AUTOIMMUNE HAEMOLYTIC ANAEMIA 17 0.0050
174 SKIN DISORDER 165 0.0049
175 GLOMERULONEPHRITIS 12 0.0049
176 LYMPHOCYTE COUNT INCREASED 16 0.0049
177 ACUTE MYELOID LEUKAEMIA 76 0.0049
178 PERIORBITAL SWELLING 27 0.0048
179 RED BLOOD CELL COUNT DECREASED 136 0.0048
180 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 34 0.0047
181 COLITIS 179 0.0047
182 HEPATITIS FULMINANT 14 0.0047
183 CONJUNCTIVAL HAEMORRHAGE 18 0.0047
184 ACUTE MYELOID LEUKAEMIA RECURRENT 10 0.0047
185 ATELECTASIS 45 0.0047
186 MYELOFIBROSIS 14 0.0046
187 PULMONARY HAEMORRHAGE 36 0.0046
188 CAROTID ARTERY STENOSIS 16 0.0046
189 LUNG OPACITY 12 0.0045
190 ACUTE PULMONARY OEDEMA 25 0.0044
191 ARTERIOSCLEROSIS 41 0.0044
192 LOWER GASTROINTESTINAL HAEMORRHAGE 32 0.0043
193 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
194 HYPERVOLAEMIA 21 0.0042
195 PLATELET COUNT INCREASED 55 0.0042
196 BACTERAEMIA 50 0.0042
197 CYTOMEGALOVIRUS INFECTION 70 0.0042
198 BLOOD COUNT ABNORMAL 63 0.0042
199 CARDIOTOXICITY 37 0.0041
200 GASTROINTESTINAL STROMAL TUMOUR 11 0.0041
201 HAEMATOLOGICAL INFECTION 10 0.0041
202 EYE OEDEMA 10 0.0041
203 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
204 WHITE BLOOD CELL COUNT DECREASED 436 0.0040
205 APLASTIC ANAEMIA 21 0.0040
206 ANAEMIA 758 0.0040
207 DERMATITIS ACNEIFORM 24 0.0039
208 RECTAL CANCER 12 0.0039
209 ENDOCARDITIS 20 0.0039
210 PETECHIAE 40 0.0038
211 NEUTROPHIL COUNT DECREASED 155 0.0038
212 VASCULAR DEVICE INFECTION 17 0.0037
213 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
214 THERAPY NON-RESPONDER 168 0.0037
215 INTENTIONAL PRODUCT USE ISSUE 327 0.0037
216 RASH 1618 0.0037
217 BACTERIAL SEPSIS 12 0.0037
218 HYDROCEPHALUS 20 0.0037
219 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
220 THYROIDITIS 11 0.0037
221 ELECTROCARDIOGRAM QT PROLONGED 131 0.0036
222 PLATELET COUNT ABNORMAL 22 0.0036
223 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0036
224 CORONARY ARTERY STENOSIS 18 0.0036
225 LUNG CONSOLIDATION 10 0.0036
226 RIGHT VENTRICULAR FAILURE 25 0.0036
227 HEPATOMEGALY 35 0.0036
228 NAIL DISCOLOURATION 14 0.0036
229 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
230 EYE SWELLING 132 0.0035
231 PAPILLOEDEMA 16 0.0035
232 BLOOD IRON DECREASED 42 0.0035
233 FACE OEDEMA 59 0.0035
234 SUNBURN 26 0.0035
235 MYALGIA 592 0.0035
236 FUNGAL SKIN INFECTION 14 0.0035
237 FAILURE TO THRIVE 18 0.0035
238 THERAPY CESSATION 176 0.0034
239 THROMBOTIC MICROANGIOPATHY 33 0.0034
240 PNEUMOCYSTIS JIROVECII PNEUMONIA 34 0.0034
241 NEPHROPATHY TOXIC 38 0.0034
242 HYPOPHOSPHATAEMIA 25 0.0034
243 DIARRHOEA 2178 0.0034
244 HYPOALBUMINAEMIA 26 0.0033
245 BLOOD CULTURE POSITIVE 10 0.0033
246 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
247 FATIGUE 2554 0.0033
248 EAR DISORDER 15 0.0033
249 DIASTOLIC DYSFUNCTION 10 0.0032
250 ACUTE RESPIRATORY FAILURE 62 0.0032
251 CARDIAC FAILURE 258 0.0032
252 HEADACHE 2014 0.0032
253 HYPOGAMMAGLOBULINAEMIA 21 0.0032
254 BLOOD CREATININE ABNORMAL 11 0.0032
255 ORTHOPNOEA 10 0.0031
256 CARDIAC FAILURE CONGESTIVE 252 0.0031
257 ERYTHEMA NODOSUM 11 0.0031
258 LABORATORY TEST ABNORMAL 92 0.0031
259 ACNE 236 0.0031
260 MYELODYSPLASTIC SYNDROME 45 0.0031
261 RETINAL HAEMORRHAGE 22 0.0031
262 FAECES HARD 12 0.0031
263 STOMATITIS 187 0.0031
264 NEUROTOXICITY 54 0.0031
265 NEUTROPENIA 419 0.0031
266 PIGMENTATION DISORDER 19 0.0031
267 BLOOD TEST ABNORMAL 43 0.0031
268 DYSPNOEA EXERTIONAL 115 0.0031
269 PULMONARY TUBERCULOSIS 13 0.0030
270 PULMONARY CONGESTION 40 0.0030
271 PHOTOSENSITIVITY REACTION 50 0.0030
272 FULL BLOOD COUNT ABNORMAL 32 0.0030
273 APPETITE DISORDER 20 0.0030
274 LYMPHADENOPATHY 106 0.0030
275 TREATMENT FAILURE 248 0.0030
276 ARTERIOSPASM CORONARY 12 0.0030
277 LEFT VENTRICULAR DYSFUNCTION 20 0.0030
278 DIFFUSE LARGE B-CELL LYMPHOMA 23 0.0030
279 PERICARDITIS 50 0.0030
280 LEUKOENCEPHALOPATHY 11 0.0030
281 GASTROINTESTINAL DISORDER 264 0.0029
282 HAEMOGLOBIN DECREASED 302 0.0029
283 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 26 0.0029
284 CARDIAC FLUTTER 19 0.0029
285 CARDIOMEGALY 36 0.0029
286 EYELID OEDEMA 34 0.0029
287 STRESS CARDIOMYOPATHY 17 0.0029
288 RESPIRATORY TRACT CONGESTION 46 0.0029
289 INTERNAL HAEMORRHAGE 33 0.0029
290 LARGE INTESTINE POLYP 20 0.0029
291 THERAPEUTIC RESPONSE DECREASED 175 0.0029
292 GASTROINTESTINAL HAEMORRHAGE 240 0.0029
293 INTRACRANIAL PRESSURE INCREASED 16 0.0029
294 SWELLING OF EYELID 18 0.0029
295 GASTRIC DISORDER 98 0.0029
296 CARDIAC FAILURE ACUTE 19 0.0028
297 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
298 FEBRILE BONE MARROW APLASIA 12 0.0028
299 GANGRENE 17 0.0028
300 SWELLING 264 0.0028
301 HAEMORRHOIDS 55 0.0028
302 LUNG DISORDER 138 0.0028
303 HEPATIC ENZYME ABNORMAL 14 0.0028
304 ELECTROCARDIOGRAM ABNORMAL 22 0.0028
305 ARTERIAL OCCLUSIVE DISEASE 22 0.0028
306 ERYSIPELAS 14 0.0028
307 NEPHROPATHY 26 0.0028
308 TRICUSPID VALVE INCOMPETENCE 22 0.0028
309 RALES 16 0.0028
310 CLOSTRIDIUM DIFFICILE INFECTION 60 0.0027
311 CARDIAC DISORDER 257 0.0027
312 THERAPY INTERRUPTED 196 0.0027
313 MUSCULOSKELETAL PAIN 143 0.0027
314 MYOCARDIAL ISCHAEMIA 31 0.0027
315 NAUSEA 2151 0.0027
316 PNEUMONITIS 74 0.0027
317 NEOPLASM PROGRESSION 94 0.0027
318 EYE HAEMORRHAGE 36 0.0027
319 ESCHERICHIA INFECTION 22 0.0027
320 DYSPNOEA 1513 0.0027
321 IRON DEFICIENCY 12 0.0027
322 BLOOD BILIRUBIN INCREASED 72 0.0027
323 ACUTE CORONARY SYNDROME 22 0.0027
324 TOOTH DISORDER 59 0.0027
325 MITRAL VALVE INCOMPETENCE 30 0.0026
326 ALOPECIA 520 0.0026
327 ACUTE MYOCARDIAL INFARCTION 78 0.0026
328 ULCER 42 0.0026
329 CONGESTIVE CARDIOMYOPATHY 11 0.0026
330 NIGHT SWEATS 85 0.0026
331 LIVE BIRTH 22 0.0026
332 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
333 CARDIAC VALVE DISEASE 15 0.0026
334 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
335 PANCREATITIS 138 0.0026
336 GINGIVAL DISORDER 10 0.0026
337 PYREXIA 898 0.0026
338 LOCALISED OEDEMA 12 0.0026
339 HYPERTRANSAMINASAEMIA 18 0.0026
340 LUNG INFECTION 40 0.0026
341 KLEBSIELLA INFECTION 13 0.0026
342 NEUROPATHY PERIPHERAL 244 0.0026
343 ORAL PAIN 57 0.0025
344 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
345 NEOPLASM MALIGNANT 169 0.0025
346 NECROSIS 14 0.0025
347 ANGIOPATHY 14 0.0025
348 RESPIRATORY FAILURE 182 0.0025
349 DECREASED APPETITE 577 0.0025
350 ASCITES 73 0.0025
351 BOWEL MOVEMENT IRREGULARITY 19 0.0025
352 DEATH 2131 0.0025
353 MUSCLE DISORDER 20 0.0025
354 TREATMENT NONCOMPLIANCE 135 0.0025
355 BLOOD LACTATE DEHYDROGENASE INCREASED 39 0.0025
356 PNEUMONIA 793 0.0024
357 OEDEMA PERIPHERAL 298 0.0024
358 INCORRECT PRODUCT STORAGE 32 0.0024
359 CONSTIPATION 531 0.0024
360 SEPSIS 271 0.0024
361 SWELLING FACE 158 0.0024
362 GASTROINTESTINAL INFLAMMATION 19 0.0024
363 BLOOD URIC ACID INCREASED 14 0.0024
364 HYPOXIA 85 0.0024
365 HYPERBILIRUBINAEMIA 25 0.0024
366 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
367 VENTRICULAR EXTRASYSTOLES 25 0.0024
368 DISEASE COMPLICATION 11 0.0024
369 IRON DEFICIENCY ANAEMIA 22 0.0024
370 HYPERCHLORHYDRIA 14 0.0024
371 PERIPHERAL SWELLING 365 0.0024
372 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
373 BACTERIAL INFECTION 44 0.0024
374 HYPERKERATOSIS 13 0.0024
375 TRANSAMINASES INCREASED 52 0.0023
376 PROCTALGIA 15 0.0023
377 CEREBRAL ISCHAEMIA 12 0.0023
378 HAEMOGLOBIN ABNORMAL 15 0.0023
379 SQUAMOUS CELL CARCINOMA OF SKIN 14 0.0023
380 RENAL DISORDER 108 0.0023
381 CARDIAC MURMUR 20 0.0023
382 LARGE INTESTINE PERFORATION 16 0.0023
383 LIVER DISORDER 102 0.0023
384 NO THERAPEUTIC RESPONSE 28 0.0023
385 CYTOKINE RELEASE SYNDROME 46 0.0023
386 HAEMORRHAGE INTRACRANIAL 34 0.0023
387 RESPIRATORY DISORDER 68 0.0023
388 PNEUMOTHORAX 36 0.0023
389 ADVERSE DRUG REACTION 201 0.0022
390 ABORTION INDUCED 21 0.0022
391 CELLULITIS 112 0.0022
392 HYPERTRIGLYCERIDAEMIA 13 0.0022
393 FAECES DISCOLOURED 48 0.0022
394 SINUS HEADACHE 13 0.0022
395 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
396 ATRIAL FIBRILLATION 213 0.0022
397 BRAIN FOG 34 0.0022
398 HYPOKALAEMIA 100 0.0022
399 GASTRITIS 57 0.0022
400 DRUG DOSE OMISSION 356 0.0022
401 DEHYDRATION 286 0.0021
402 PERFORMANCE STATUS DECREASED 10 0.0021
403 GINGIVAL PAIN 17 0.0021
404 VENTRICULAR TACHYCARDIA 35 0.0021
405 RASH MACULO-PAPULAR 47 0.0021
406 CHEST PAIN 391 0.0021
407 NEUTROPHILIA 12 0.0021
408 INTERSTITIAL LUNG DISEASE 102 0.0021
409 POST PROCEDURAL INFECTION 17 0.0021
410 HERPES VIRUS INFECTION 12 0.0021
411 GUILLAIN-BARRE SYNDROME 10 0.0021
412 ANAL FISSURE 11 0.0020
413 HAEMORRHOIDAL HAEMORRHAGE 10 0.0020
414 HAEMATOCHEZIA 113 0.0020
415 MELAENA 45 0.0020
416 VOMITING 961 0.0020
417 DECREASED ACTIVITY 22 0.0020
418 BLOOD CREATININE INCREASED 133 0.0020
419 GASTROINTESTINAL INFECTION 18 0.0020
420 NONSPECIFIC REACTION 11 0.0020
421 HERPES SIMPLEX 13 0.0020
422 MUSCLE SPASMS 367 0.0020
423 GASTRIC HAEMORRHAGE 23 0.0020
424 PROSTATIC DISORDER 11 0.0020
425 FLATULENCE 113 0.0020
426 INFECTION 288 0.0020
427 TASTE DISORDER 40 0.0020
428 HAEMATOCRIT DECREASED 39 0.0020
429 SHOCK HAEMORRHAGIC 16 0.0020
430 CARDIOMYOPATHY 29 0.0020
431 ABDOMINAL DISCOMFORT 329 0.0020
432 ABDOMINAL PAIN 455 0.0020
433 GASTROOESOPHAGEAL REFLUX DISEASE 157 0.0019
434 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
435 PRODUCT DISTRIBUTION ISSUE 18 0.0019
436 ATRIOVENTRICULAR BLOCK 15 0.0019
437 WEIGHT INCREASED 434 0.0019
438 TOOTHACHE 35 0.0019
439 EJECTION FRACTION DECREASED 30 0.0019
440 PALPITATIONS 226 0.0019
441 IMMUNOSUPPRESSION 17 0.0019
442 EATING DISORDER 41 0.0019
443 FLUID OVERLOAD 28 0.0019
444 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
445 OESOPHAGITIS 21 0.0019
446 LEUKOPENIA 96 0.0019
447 MALABSORPTION 10 0.0019
448 INABILITY TO AFFORD MEDICATION 19 0.0019
449 MOUTH HAEMORRHAGE 14 0.0019
450 LYMPHOPENIA 27 0.0019
451 MENTAL STATUS CHANGES 53 0.0019
452 INSURANCE ISSUE 29 0.0019
453 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
454 PROTEINURIA 36 0.0019
455 FURUNCLE 15 0.0019
456 ARTHROPOD BITE 14 0.0019
457 TOXIC SKIN ERUPTION 19 0.0019
458 PULMONARY MASS 28 0.0019
459 COLON CANCER 28 0.0019
460 ENTERITIS 12 0.0019
461 LYMPHOCYTE COUNT DECREASED 33 0.0019
462 RECTAL HAEMORRHAGE 80 0.0019
463 INCREASED TENDENCY TO BRUISE 17 0.0018
464 HEPATITIS ACUTE 12 0.0018
465 DYSPEPSIA 181 0.0018
466 GOUT 33 0.0018
467 RENAL FAILURE ACUTE 78 0.0018
468 HEPATOCELLULAR INJURY 26 0.0018
469 DERMATITIS ALLERGIC 23 0.0018
470 GASTROENTERITIS VIRAL 33 0.0018
471 COUGH 512 0.0018
472 PRODUCT SUPPLY ISSUE 13 0.0018
473 PERIPHERAL COLDNESS 25 0.0018
474 RASH GENERALISED 47 0.0018
475 HEART RATE IRREGULAR 41 0.0018
476 MOUTH ULCERATION 38 0.0018
477 EOSINOPHIL COUNT INCREASED 15 0.0018
478 GALLBLADDER DISORDER 32 0.0018
479 ENCEPHALOPATHY 44 0.0018
480 WEIGHT DECREASED 500 0.0018
481 BACK DISORDER 29 0.0018
482 SKIN ULCER 46 0.0018
483 MYELOSUPPRESSION 64 0.0018
484 ILEUS 22 0.0018
485 FUNGAL INFECTION 59 0.0018
486 AGEUSIA 44 0.0018
487 CEREBRAL DISORDER 13 0.0018
488 MATERNAL EXPOSURE BEFORE PREGNANCY 12 0.0018
489 DEVICE RELATED INFECTION 27 0.0018
490 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
491 HEPATIC FUNCTION ABNORMAL 65 0.0017
492 CORONARY ARTERY BYPASS 10 0.0017
493 MOUTH SWELLING 10 0.0017
494 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 13 0.0017
495 SEPTIC SHOCK 75 0.0017
496 DRUG INTERACTION 273 0.0017
497 FOLLICULITIS 18 0.0017
498 RASH PRURITIC 93 0.0017
499 RENAL IMPAIRMENT 144 0.0017
500 GASTROENTERITIS 25 0.0017
501 HAEMORRHAGE 179 0.0017
502 ABDOMINAL DISTENSION 178 0.0017
503 RENAL FAILURE 226 0.0017
504 SKIN DISCOLOURATION 78 0.0017
505 LOCALISED INFECTION 41 0.0017
506 CARDIOVASCULAR DISORDER 43 0.0017
507 GINGIVAL BLEEDING 23 0.0017
508 GASTRIC ULCER 32 0.0017
509 DISEASE RECURRENCE 80 0.0017
510 LIVER FUNCTION TEST INCREASED 36 0.0017
511 ASPERGILLUS INFECTION 11 0.0017
512 MYOSITIS 15 0.0017
513 IMMUNE SYSTEM DISORDER 22 0.0017
514 ARTHRALGIA 694 0.0017
515 CORONAVIRUS INFECTION 11 0.0017
516 MENINGITIS 11 0.0016
517 UPPER RESPIRATORY TRACT INFECTION 76 0.0016
518 AMNESIA 107 0.0016
519 MIGRAINE 156 0.0016
520 DECREASED IMMUNE RESPONSIVENESS 16 0.0016
521 ATRIAL FLUTTER 13 0.0016
522 ALANINE AMINOTRANSFERASE INCREASED 100 0.0016
523 ULCER HAEMORRHAGE 11 0.0016
524 HOSPICE CARE 16 0.0016
525 MUSCLE STRAIN 14 0.0016
526 TACHYPNOEA 22 0.0016
527 LYMPHOMA 25 0.0016
528 ABDOMINAL PAIN UPPER 333 0.0016
529 PYELONEPHRITIS 14 0.0016
530 MUSCULOSKELETAL CHEST PAIN 25 0.0016
531 APPENDICITIS 15 0.0016
532 CHILLS 187 0.0016
533 CHOLECYSTITIS 19 0.0016
534 MATERNAL EXPOSURE DURING PREGNANCY 142 0.0016
535 POLYNEUROPATHY 19 0.0016
536 BLISTER 89 0.0016
537 BRAIN OEDEMA 20 0.0016
538 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
539 MASS 22 0.0016
540 MYOCARDITIS 18 0.0016
541 BODY TEMPERATURE INCREASED 32 0.0016
542 HYPERGLYCAEMIA 57 0.0016
543 PULMONARY FIBROSIS 30 0.0016
544 ASPARTATE AMINOTRANSFERASE INCREASED 83 0.0016
545 SEASONAL ALLERGY 22 0.0016
546 HYPERTENSION 329 0.0016
547 DIVERTICULUM 11 0.0015
548 HEPATIC CIRRHOSIS 29 0.0015
549 NEUTROPENIC SEPSIS 11 0.0015
550 BLOOD POTASSIUM INCREASED 25 0.0015
551 THERAPY PARTIAL RESPONDER 24 0.0015
552 CEREBRAL HAEMORRHAGE 55 0.0015
553 VENTRICULAR FIBRILLATION 17 0.0015
554 HAIR COLOUR CHANGES 19 0.0015
555 COVID-19 PNEUMONIA 18 0.0015
556 DISEASE PROGRESSION 180 0.0015
557 ATAXIA 18 0.0015
558 PSEUDOMONAS INFECTION 13 0.0015
559 SUDDEN DEATH 16 0.0015
560 OFF LABEL USE 1321 0.0015
561 AGRANULOCYTOSIS 28 0.0015
562 MYOPATHY 13 0.0015
563 DIARRHOEA HAEMORRHAGIC 14 0.0015
564 BLOOD UREA INCREASED 25 0.0015
565 SKIN REACTION 21 0.0015
566 PRODUCT DOSE OMISSION 97 0.0015
567 IMMUNODEFICIENCY 22 0.0015
568 HIATUS HERNIA 19 0.0015
569 PAIN IN EXTREMITY 432 0.0015
570 CHEST DISCOMFORT 150 0.0015
571 CONTUSION 141 0.0015
572 HYPOAESTHESIA 219 0.0015
573 INFARCTION 10 0.0015
574 EPISTAXIS 109 0.0015
575 ISCHAEMIC STROKE 26 0.0015
576 GASTROINTESTINAL PAIN 16 0.0015
577 ENCEPHALITIS 10 0.0014
578 ASTHENIA 543 0.0014
579 ABSCESS 23 0.0014
580 POOR QUALITY SLEEP 31 0.0014
581 HEPATIC ENZYME INCREASED 98 0.0014
582 ARRHYTHMIA 68 0.0014
583 ANGINA PECTORIS 41 0.0014
584 PHARYNGEAL SWELLING 14 0.0014
585 FEEDING DISORDER 29 0.0014
586 HYPOCALCAEMIA 27 0.0014
587 DYSPHAGIA 135 0.0014
588 HEAD DISCOMFORT 25 0.0014
589 GLAUCOMA 27 0.0014
590 FEELING COLD 39 0.0014
591 SALIVARY HYPERSECRETION 14 0.0014
592 NEURALGIA 34 0.0014
593 ANURIA 12 0.0014
594 TINNITUS 64 0.0014
595 BRONCHITIS 103 0.0014
596 LACRIMATION INCREASED 42 0.0014
597 HAEMATOMA 36 0.0014
598 NASOPHARYNGITIS 256 0.0014
599 MULTI-ORGAN FAILURE 24 0.0014
600 EMPHYSEMA 14 0.0014
601 CORONARY ARTERY DISEASE 42 0.0014
602 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
603 RASH PAPULAR 31 0.0014
604 SMALL INTESTINAL OBSTRUCTION 17 0.0014
605 SQUAMOUS CELL CARCINOMA 13 0.0014
606 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
607 NERVOUS SYSTEM DISORDER 43 0.0014
608 HYPERCALCAEMIA 17 0.0014
609 BLINDNESS 56 0.0014
610 RASH MACULAR 48 0.0014
611 EOSINOPHILIA 24 0.0014
612 HYPOPHAGIA 35 0.0014
613 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
614 GROIN PAIN 12 0.0014
615 ORAL DISORDER 10 0.0014
616 STENT PLACEMENT 11 0.0014
617 PRODUCTIVE COUGH 65 0.0014
618 HYPERTENSIVE CRISIS 15 0.0013
619 HYPOACUSIS 58 0.0013
620 HYPERCHOLESTEROLAEMIA 13 0.0013
621 DYSGEUSIA 100 0.0013
622 FACIAL PAIN 12 0.0013
623 POLYURIA 11 0.0013
624 HAEMOLYTIC ANAEMIA 12 0.0013
625 LETHARGY 77 0.0013
626 MYOCARDIAL INFARCTION 232 0.0013
627 CARDIOGENIC SHOCK 19 0.0013
628 BLOOD URINE PRESENT 25 0.0013
629 MALAISE 577 0.0013
630 SKIN LESION 36 0.0013
631 INFLUENZA 146 0.0013
632 PNEUMONIA BACTERIAL 12 0.0013
633 LIVER FUNCTION TEST ABNORMAL 38 0.0013
634 STAPHYLOCOCCAL INFECTION 43 0.0013
635 ILLNESS 134 0.0013
636 JAUNDICE 35 0.0013
637 PRODUCT STORAGE ERROR 113 0.0013
638 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
639 APHTHOUS ULCER 10 0.0013
640 EAR PAIN 25 0.0013
641 BLOOD CREATINE PHOSPHOKINASE INCREASED 37 0.0013
642 FLANK PAIN 12 0.0013
643 EYE DISORDER 42 0.0013
644 PAIN 784 0.0013
645 GENERAL PHYSICAL HEALTH DETERIORATION 147 0.0013
646 NEUTROPHIL COUNT INCREASED 13 0.0013
647 RESPIRATORY DISTRESS 35 0.0013
648 SINUS TACHYCARDIA 18 0.0013
649 RESPIRATORY TRACT INFECTION 33 0.0013
650 EAR DISCOMFORT 13 0.0013
651 HELICOBACTER INFECTION 13 0.0013
652 LIVER INJURY 31 0.0013
653 LIMB DISCOMFORT 39 0.0013
654 DIABETES MELLITUS 96 0.0013
655 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0012
656 HYPONATRAEMIA 70 0.0012
657 WEIGHT FLUCTUATION 13 0.0012
658 ANOREXIA 16 0.0012
659 DERMATITIS 26 0.0012
660 RHINORRHOEA 80 0.0012
661 DRY SKIN 165 0.0012
662 HYPERSENSITIVITY 229 0.0012
663 VIRAL INFECTION 41 0.0012
664 BACK PAIN 286 0.0012
665 ACUTE KIDNEY INJURY 188 0.0012
666 GAIT INABILITY 41 0.0012
667 RENAL PAIN 13 0.0012
668 RENAL TUBULAR NECROSIS 12 0.0012
669 HAEMATEMESIS 31 0.0012
670 HYPOTHYROIDISM 39 0.0012
671 SINUS DISORDER 24 0.0012
672 OPTIC NEURITIS 11 0.0012
673 PANCREATITIS ACUTE 27 0.0012
674 COGNITIVE DISORDER 56 0.0012
675 BLOOD POTASSIUM DECREASED 36 0.0012
676 MENTAL IMPAIRMENT 29 0.0012
677 OVARIAN CANCER 11 0.0012
678 PRURITUS 454 0.0012
679 DRUG INEFFECTIVE 1554 0.0012
680 HYPOKINESIA 17 0.0012
681 PHOTOPHOBIA 22 0.0012
682 ARTHROPATHY 65 0.0012
683 PULMONARY EMBOLISM 111 0.0012
684 HEART RATE INCREASED 115 0.0012
685 OSTEOMYELITIS 21 0.0012
686 SKIN INFECTION 13 0.0012
687 BASAL CELL CARCINOMA 18 0.0012
688 HYPOMAGNESAEMIA 16 0.0011
689 OROPHARYNGEAL PAIN 106 0.0011
690 MEMORY IMPAIRMENT 157 0.0011
691 TOOTH INFECTION 15 0.0011
692 VISUAL IMPAIRMENT 141 0.0011
693 PRESCRIBED OVERDOSE 22 0.0011
694 DEPRESSION 258 0.0011
695 CONJUNCTIVITIS 21 0.0011
696 HERPES ZOSTER 65 0.0011
697 NEOPLASM 13 0.0011
698 HEPATIC FAILURE 34 0.0011
699 INFLAMMATION 58 0.0011
700 MADAROSIS 13 0.0011
701 COLITIS ULCERATIVE 50 0.0011
702 HEAVY MENSTRUAL BLEEDING 10 0.0011
703 BLOOD PRESSURE ABNORMAL 22 0.0011
704 HYPERTHYROIDISM 16 0.0011
705 BACK INJURY 12 0.0011
706 THYROID DISORDER 17 0.0011
707 HOT FLUSH 83 0.0011
708 SINUSITIS 112 0.0011
709 TACHYCARDIA 97 0.0011
710 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
711 HYPERSOMNIA 31 0.0011
712 SUBARACHNOID HAEMORRHAGE 11 0.0011
713 SLUGGISHNESS 11 0.0011
714 JOINT SWELLING 130 0.0011
715 ADRENAL INSUFFICIENCY 13 0.0011
716 TEMPERATURE INTOLERANCE 11 0.0011
717 CANDIDA INFECTION 18 0.0011
718 CIRCULATORY COLLAPSE 18 0.0011
719 DIZZINESS 526 0.0011
720 URINARY TRACT INFECTION 178 0.0010
721 SURGERY 61 0.0010
722 SECRETION DISCHARGE 13 0.0010
723 POLLAKIURIA 43 0.0010
724 APHASIA 31 0.0010
725 NEPHROLITHIASIS 47 0.0010
726 CEREBRAL INFARCTION 25 0.0010
727 MENORRHAGIA 20 0.0010
728 PHARYNGITIS STREPTOCOCCAL 11 0.0010
729 EAR INFECTION 27 0.0010
730 BURNING SENSATION 71 0.0010
731 COVID-19 177 0.0010
732 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
733 DRY EYE 50 0.0010
734 PARAESTHESIA 157 0.0010
735 VISION BLURRED 137 0.0010
736 THROMBOSIS 80 0.0010
737 INCREASED APPETITE 19 0.0010
738 PRODUCT USE ISSUE 186 0.0010
739 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
740 MUSCULOSKELETAL DISCOMFORT 17 0.0010
741 MUSCLE TIGHTNESS 16 0.0010
742 DIALYSIS 14 0.0010
743 SNEEZING 22 0.0010
744 CEREBROVASCULAR ACCIDENT 166 0.0010
745 HEPATITIS 25 0.0010
746 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33 0.0010
747 MUSCULAR WEAKNESS 111 0.0010
748 DIVERTICULITIS 27 0.0010
749 LUNG NEOPLASM MALIGNANT 40 0.0010
750 SKIN EXFOLIATION 82 0.0010
751 HAIR TEXTURE ABNORMAL 13 0.0010
752 CYST 12 0.0010
753 DEMENTIA 27 0.0010
754 PRODUCT DISPENSING ERROR 21 0.0010
755 HAEMATURIA 33 0.0010
756 SWOLLEN TONGUE 30 0.0010
757 URINARY RETENTION 32 0.0010
758 CATARACT 57 0.0010
759 BLOOD SODIUM DECREASED 18 0.0010
760 ELECTROLYTE IMBALANCE 11 0.0009
761 VASCULITIS 11 0.0009
762 MENTAL DISORDER 41 0.0009
763 PRODUCT PHYSICAL ISSUE 19 0.0009
764 RASH ERYTHEMATOUS 45 0.0009
765 HYPERKALAEMIA 33 0.0009
766 SPINAL PAIN 11 0.0009
767 CHOLESTASIS 18 0.0009
768 CARDIAC ARREST 77 0.0009
769 TOXICITY TO VARIOUS AGENTS 157 0.0009
770 NECK PAIN 52 0.0009
771 DYSSTASIA 27 0.0009
772 BLINDNESS UNILATERAL 13 0.0009
773 INSOMNIA 244 0.0009
774 ANGIOEDEMA 40 0.0009
775 DENTAL CARIES 10 0.0009
776 PRODUCT DOSE OMISSION ISSUE 265 0.0009
777 BLOOD CHOLESTEROL INCREASED 42 0.0009
778 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
779 THIRST 16 0.0009
780 MALNUTRITION 10 0.0009
781 FEELING ABNORMAL 214 0.0009
782 URTICARIA 149 0.0009
783 SINUS CONGESTION 12 0.0009
784 VERTIGO 54 0.0009
785 EYE INFECTION 10 0.0009
786 CONFUSIONAL STATE 143 0.0009
787 IMPAIRED HEALING 29 0.0009
788 PALLOR 24 0.0009
789 BONE DISORDER 16 0.0009
790 PERITONITIS 18 0.0009
791 ANXIETY 245 0.0009
792 LOCAL SWELLING 15 0.0009
793 APHONIA 12 0.0009
794 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
795 DYSPHONIA 50 0.0009
796 PAIN OF SKIN 23 0.0009
797 FREQUENT BOWEL MOVEMENTS 23 0.0009
798 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
799 PAIN IN JAW 24 0.0008
800 FRACTURE 16 0.0008
801 BLOOD PRESSURE INCREASED 129 0.0008
802 JOINT INJURY 18 0.0008
803 DEAFNESS 22 0.0008
804 SPEECH DISORDER 44 0.0008
805 IRRITABLE BOWEL SYNDROME 18 0.0008
806 SLEEP APNOEA SYNDROME 16 0.0008
807 ADVERSE REACTION 11 0.0008
808 HERNIA 16 0.0008
809 HEMIPARESIS 14 0.0008
810 HAEMOPTYSIS 23 0.0008
811 OCULAR HYPERAEMIA 39 0.0008
812 ORAL HERPES 16 0.0008
813 PREMATURE DELIVERY 13 0.0008
814 KIDNEY INFECTION 16 0.0008
815 CARDIO-RESPIRATORY ARREST 34 0.0008
816 DIPLOPIA 21 0.0008
817 ACUTE HEPATIC FAILURE 11 0.0008
818 EYE PRURITUS 27 0.0008
819 FEELING HOT 49 0.0008
820 PROSTATIC SPECIFIC ANTIGEN INCREASED 11 0.0008
821 ERYTHEMA 164 0.0008
822 CHOLELITHIASIS 26 0.0008
823 METASTASES TO BONE 13 0.0008
824 DRUG ERUPTION 14 0.0008
825 SKIN CANCER 17 0.0008
826 COORDINATION ABNORMAL 11 0.0008
827 HEPATIC CYTOLYSIS 10 0.0008
828 INTRAOCULAR PRESSURE INCREASED 10 0.0008
829 COAGULOPATHY 13 0.0008
830 PHARYNGEAL OEDEMA 12 0.0008
831 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
832 INFLUENZA LIKE ILLNESS 64 0.0008
833 ERUCTATION 15 0.0008
834 BLOOD GLUCOSE DECREASED 37 0.0008
835 PRODUCT USE IN UNAPPROVED INDICATION 190 0.0008
836 STEVENS-JOHNSON SYNDROME 17 0.0008
837 DYSURIA 28 0.0008
838 PNEUMONIA ASPIRATION 19 0.0008
839 WHEEZING 45 0.0008
840 HEAD INJURY 24 0.0008
841 LIP SWELLING 25 0.0007
842 RETCHING 16 0.0007
843 DELIRIUM 26 0.0007
844 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
845 ERECTILE DYSFUNCTION 19 0.0007
846 METASTASES TO LIVER 13 0.0007
847 DRY MOUTH 60 0.0007
848 SHOCK 17 0.0007
849 HYPOTENSION 147 0.0007
850 ARTHRITIS 57 0.0007
851 TOOTH LOSS 15 0.0007
852 DEEP VEIN THROMBOSIS 47 0.0007
853 SLEEP DISORDER 51 0.0007
854 SEIZURE 83 0.0007
855 DYSARTHRIA 27 0.0007
856 MOVEMENT DISORDER 23 0.0007
857 TENDONITIS 11 0.0007
858 CHROMATURIA 16 0.0007
859 DISTURBANCE IN ATTENTION 38 0.0007
860 BLOOD GLUCOSE ABNORMAL 13 0.0007
861 UPPER LIMB FRACTURE 14 0.0007
862 LIMB INJURY 19 0.0007
863 PARALYSIS 10 0.0007
864 GAIT DISTURBANCE 133 0.0007
865 ROAD TRAFFIC ACCIDENT 29 0.0007
866 OBESITY 11 0.0007
867 SCIATICA 11 0.0007
868 INTESTINAL OBSTRUCTION 26 0.0007
869 RESPIRATORY ARREST 19 0.0007
870 JOINT STIFFNESS 18 0.0007
871 PANIC ATTACK 25 0.0007
872 RHABDOMYOLYSIS 28 0.0007
873 HYPERHIDROSIS 86 0.0007
874 DRUG LEVEL INCREASED 11 0.0007
875 FLUSHING 67 0.0007
876 BLOOD PRESSURE DECREASED 43 0.0006
877 NASAL CONGESTION 38 0.0006
878 GYNAECOMASTIA 20 0.0006
879 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
880 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
881 FOOT FRACTURE 12 0.0006
882 ABDOMINAL PAIN LOWER 16 0.0006
883 PREMATURE BABY 19 0.0006
884 SOMNOLENCE 127 0.0006
885 COMA 30 0.0006
886 FEELING JITTERY 12 0.0006
887 CYSTITIS 20 0.0006
888 LOWER LIMB FRACTURE 12 0.0006
889 OSTEONECROSIS 20 0.0006
890 MUSCULOSKELETAL STIFFNESS 53 0.0006
891 RESTLESS LEGS SYNDROME 11 0.0006
892 BRADYCARDIA 32 0.0006
893 END STAGE RENAL DISEASE 11 0.0006
894 EYE PAIN 34 0.0006
895 PRURITUS GENERALISED 13 0.0006
896 LOSS OF CONSCIOUSNESS 77 0.0006
897 HEPATIC STEATOSIS 11 0.0006
898 FALL 195 0.0006
899 SYNCOPE 58 0.0006
900 PRESYNCOPE 14 0.0006
901 ACCIDENTAL OVERDOSE 21 0.0006
902 URINARY INCONTINENCE 17 0.0006
903 DISCOMFORT 35 0.0006
904 ECZEMA 30 0.0006
905 POST PROCEDURAL COMPLICATION 11 0.0006
906 ASTHMA 64 0.0006
907 HIP FRACTURE 18 0.0006
908 ABORTION SPONTANEOUS 22 0.0005
909 DEPRESSED MOOD 29 0.0005
910 PRODUCT ADMINISTRATION ERROR 11 0.0005
911 HYPOGLYCAEMIA 26 0.0005
912 ILL-DEFINED DISORDER 32 0.0005
913 INTENTIONAL DOSE OMISSION 15 0.0005
914 SKIN IRRITATION 24 0.0005
915 EPILEPSY 16 0.0005
916 KNEE ARTHROPLASTY 11 0.0005
917 C-REACTIVE PROTEIN INCREASED 19 0.0005
918 UNDERDOSE 38 0.0005
919 RESTLESSNESS 19 0.0005
920 VISUAL ACUITY REDUCED 17 0.0005
921 BALANCE DISORDER 44 0.0005
922 BLOOD PRESSURE FLUCTUATION 12 0.0005
923 GLOSSODYNIA 11 0.0005
924 THROAT IRRITATION 22 0.0005
925 ANAPHYLACTIC REACTION 27 0.0005
926 OSTEONECROSIS OF JAW 12 0.0005
927 HEART RATE DECREASED 17 0.0005
928 NERVOUSNESS 25 0.0005
929 TYPE 2 DIABETES MELLITUS 16 0.0005
930 GASTRIC CANCER 12 0.0005
931 CONDITION AGGRAVATED 143 0.0005
932 OXYGEN SATURATION DECREASED 26 0.0005
933 NIGHTMARE 16 0.0005
934 VAGINAL HAEMORRHAGE 20 0.0005
935 DISORIENTATION 18 0.0005
936 FIBROMYALGIA 11 0.0005
937 BLOOD GLUCOSE INCREASED 85 0.0005
938 MEDICATION ERROR 25 0.0004
939 OSTEOARTHRITIS 19 0.0004
940 CHRONIC KIDNEY DISEASE 34 0.0004
941 DRUG-INDUCED LIVER INJURY 14 0.0004
942 THROAT TIGHTNESS 12 0.0004
943 TREMOR 73 0.0004
944 MOOD SWINGS 14 0.0004
945 ANAPHYLACTIC SHOCK 11 0.0004
946 CRYING 15 0.0004
947 MOOD ALTERED 11 0.0004
948 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
949 PRODUCT SUBSTITUTION ISSUE 23 0.0004
950 PROSTATE CANCER 32 0.0004
951 IRRITABILITY 23 0.0004
952 FOETAL EXPOSURE DURING PREGNANCY 31 0.0004
953 AGITATION 28 0.0004
954 RENAL INJURY 11 0.0004
955 BREAST CANCER 34 0.0004
956 NO ADVERSE EVENT 65 0.0004
957 UNEVALUABLE EVENT 27 0.0004
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0004
959 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
960 EYE IRRITATION 20 0.0003
961 OSTEOPOROSIS 14 0.0003
962 RENAL CANCER 16 0.0003
963 SKIN BURNING SENSATION 24 0.0003
964 EMOTIONAL DISORDER 10 0.0003
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
966 SUICIDE ATTEMPT 19 0.0003
967 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11 0.0003
968 CONVULSION 17 0.0003
969 ANGER 10 0.0003
970 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
971 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
972 WITHDRAWAL SYNDROME 12 0.0003
973 INCORRECT DOSE ADMINISTERED 63 0.0003
974 DRUG EFFECT INCOMPLETE 10 0.0003
975 SUICIDAL IDEATION 25 0.0003
976 EXTRA DOSE ADMINISTERED 11 0.0003
977 INJURY 19 0.0003
978 BLADDER CANCER 15 0.0003
979 HALLUCINATION 19 0.0003
980 MULTIPLE SCLEROSIS 12 0.0003
981 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
982 INTENTIONAL PRODUCT MISUSE 21 0.0002
983 MOBILITY DECREASED 17 0.0002
984 OVERDOSE 49 0.0002
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
986 INFUSION RELATED REACTION 12 0.0002
987 PRODUCT QUALITY ISSUE 21 0.0002
988 EMOTIONAL DISTRESS 17 0.0001
989 PSORIASIS 15 0.0001
990 RHEUMATOID ARTHRITIS 12 0.0001